|
|
||||||||
1 in SP-A preparations influence immune suppressive properties of SP-A on human CD4+ T lymphocytes
1University Children's Hospital, Würzburg, Germany; 2Department of Cell Biology, Duke University Medical Center, Durham, North Carolina; 3Altana Pharma AG, Konstanz, Germany; and 4Swiss Institute of Allergy and Asthma Research, Davos, Switzerland
Submitted 19 September 2005 ; accepted in final form 19 April 2006
Surfactant protein A (SP-A) and transforming growth factor-
1 (TGF-
1) have been shown to modulate the functions of different immune cells and specifically to inhibit T lymphocyte proliferation. The aim of the present study was to elucidate whether the Smad signaling pathway, which is activated by TGF-
1, also plays a role in SP-A-mediated inhibition of CD4+ T lymphocyte activation. Recombinant human SP-A1 expressed in Chinese hamster ovary cells [rSP-A1m (mammalian)], but not recombinant Baculovirus-derived rSP-A1hyp (hydroxyproline-deficient), suppressed T lymphocyte proliferation and IL-2 mRNA expression. To test whether SP-A induced Smad signaling, a Smad3/4-specific reporter gene was transfected in primary human CD4+ T lymphocytes. Only rSP-A1m, but not rSP-A1hyp, induced Smad-specific reporter genes, Smad2 phosphorylation, and Smad7 mRNA expression. The effect of rSP-A1m was mediated through the TGF-
RII and could be antagonized by anti-TGF-
1 neutralizing antibodies and sTGF-
RII. Western blot and ELISA analysis revealed that rSP-A1m, but not rSP-A1hyp, contained TGF-
1. TGF-
1 was responsible for the differences in inhibition of CD4+ T lymphocyte proliferation and activation of the Smad signaling pathway between rSP-A1m and rSP-A1hyp. After acidification, native SP-A, obtained from patients with alveolar proteinosis, also induced Smad signaling in human CD4+ T lymphocytes leading to an increased inhibition of T lymphocyte proliferation, thus indicating the presence of inactive, latent TGF-
1 in native SP-A samples. Association between SP-A and latent TGF-
1 provides a possible novel mechanism to regulate TGF-
1-mediated inflammation and fibrosis reactions in the lung but also leads to possible misinterpretation of immune-modulator functions of SP-A. Monitoring of SP-A preparations for possible TGF-
1 is essential.
Smad signaling; acidification; surfactant protein A; transforming growth factor-
1
This article has been cited by other articles:
![]() |
B. Samten, J. C. Townsend, Z. Sever-Chroneos, V. Pasquinelli, P. F. Barnes, and Z. C. Chroneos An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis J. Leukoc. Biol., July 1, 2008; 84(1): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Pastva, J. R. Wright, and K. L. Williams Immunomodulatory Roles of Surfactant Proteins A and D: Implications in Lung Disease Proceedings of the ATS, July 1, 2007; 4(3): 252 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wright The "wisdom" of lung surfactant: balancing host defense and surface tension-reducing functions Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L847 - L850. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |